Ignite Creation Date:
2024-05-05 @ 9:22 PM
Last Modification Date:
2024-10-26 @ 10:04 AM
Study NCT ID:
NCT00878930
Status:
COMPLETED
Last Update Posted:
2011-01-05
First Post:
2009-04-08
Brief Title:
Parameters of Acceptability Compliance and Efficacy of Fulvestrant in Post-menopausal Patients With Advance Breast Cancer
Sponsor:
Organization:
AstraZeneca
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
500
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 7739 |
Who Masked List: